Oral cancer typically presents as a very malignant tumor. More than 90 percent of oral cancers are squamous cell carcinoma which also is one of the most common malignant types occurring lung, skin, and ovary. At advanced stage, p53 is mutated in about 60 percent of tumors and the effectiveness of chemotherapy and radiotherapy has been very disappointing. Therefore, improving the efficacy of these therapies has become an urgent topic for both clinical oncologists and basic scientists. There is increasing evidence that apoptosis plays a critical role in the response to chemotherapy and radiotherapy. Resistance to apoptosis is likely to serve as a primary mechanism whereby tumor cells are able to escape chemo- and radio-therapy killing. Recently, this laboratory has observed that the transcription factor NF-kappaB is activated by several chemotherapeutic compounds and ionizing irradiation, and inhibition of NF-kappaB enhanced the apoptotic response of these stimuli in human fibrosarcoma model system in vitro and in vivo.
The specific aims proposed in this application are the following: 1). Determine whether chemotherapy and radiotherapy activate NF- kappaB in oral squamous cell carcinoma and whether inhibition of NF-kappaB potentiates apoptosis of oral SCC induced by these therapies in vitro. 2). Explore the molecular mechanisms involved in NF-kappaB suppression of cancer therapy-mediated apoptosis. The role of NF-kappaB-induced genes c-IAP1 and 2 will be examined. 3). Determine whether inhibition of NF-kappaB as a neoadjuvant will enhance the efficacy of oral cancer therapy in a nude mouse model. We will utilize adenovirus-mediated delivery of super-repressor-IkappaBalpha and proteasome inhibitors to block the activation of NF-kappaB in vivo and determine whether these approaches will effectively inhibit the tumor growth in vivo. 4). Identify chemo- and radio-resistant genes by genetic screening. By using a unique cell line HT1080I cells that is sensitive to cancer therapy-induced apoptosis, efforts will be made to identify chemo- and radio-resistant genes from oral squamous cell carcinoma utilizing retroviral cDNA-based functional cloning. These studies will uncover the genetic mechanism of oral cancer resistance to cancer therapy and have an important implication in improving the efficacy of oral cancer therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE013788-01
Application #
2827938
Study Section
Special Emphasis Panel (ZDE1-GH (03))
Program Officer
Wolpert, Mary K
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Biology
Type
Schools of Dentistry
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Fribley, Andrew; Zeng, Qinghua; Wang, Cun-Yu (2004) Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 24:9695-704
Zeng, Qinghua; McCauley, Laurie K; Wang, Cun-Yu (2002) Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression. J Biol Chem 277:50137-42
You, Zongbing; Saims, Daniel; Chen, Shaoqiong et al. (2002) Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 157:429-40
Zeng, Qinghua; Chen, Shaoqiong; You, Zongbing et al. (2002) Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. J Biol Chem 277:25203-8
Chen, S; Fribley, A; Wang, C Y (2002) Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NF-kappaB inhibitor. J Dent Res 81:98-102
Reuther-Madrid, Julie Y; Kashatus, David; Chen, Shaoqiong et al. (2002) The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol 22:8175-83
Chen, Hen-Li; Demiralp, Burak; Schneider, Abraham et al. (2002) Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277:19374-81
You, Zongbing; Madrid, Lee V; Saims, Daniel et al. (2002) c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation. J Biol Chem 277:36671-7
You, Z; Ouyang, H; Lopatin, D et al. (2001) Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 276:26398-404
Chen, S; Guttridge, D C; Tang, E et al. (2001) Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling. J Biol Chem 276:39259-63

Showing the most recent 10 out of 11 publications